• Order to parcel locker

    Order to parcel locker
  • easy pay

    easy pay
  • Reduced price
Advances in Oncology, 2022

Advances in Oncology, 2022

9780323986694
PRINT ON DEMAND - DELIVERY CAN TAKE UP TO 14 DAYS
881.95 zł
749.66 zł Save 132.29 zł Tax included
Lowest price within 30 days before promotion: 749.66 zł
Quantity
Available in 4-6 weeks

  Delivery policy

Choose Paczkomat Inpost, Orlen Paczka, DPD or Poczta Polska. Click for more details

  Security policy

Pay with a quick bank transfer, payment card or cash on delivery. Click for more details

  Return policy

If you are a consumer, you can return the goods within 14 days. Click for more details

Description
Advances in Oncology reviews the years most important findings and updates within the cancer field for the practicing oncologist. A distinguished editorial board, led by Dr. Leonidas C. Platanias, identifies key areas of major progress and controversy and invites preeminent specialists to contribute original articles devoted to these topics. These insightful overviews in oncology inform and enhance clinical practice by  bringing concepts to a clinical level and exploring their everyday impact on patient care.
Product Details
Elsevier
92158
9780323986694
9780323986694

Data sheet

Publication date
2022
Issue number
1
Cover
hard cover
Pages count
240
Weight (g)
750
  • Neoadjuvant Chemotherapy for Nonmetastatic Breast Cancer: How Response Impacts Locoregional and Adjuvant Systemic Therapy Decision Making
    Contemporary Multimodal Management of Primary Retroperitoneal Sarcomas
    NTRK Inhibitors in Adult Patients with Solid Tumors
    The Landscape of Personalized Medicine in Gynecologic Cancer
    Geriatric Assessments: Tools for Every Oncologist to Stage the Aging When Caring for Older Adults with Cancer
    Sentinel Lymph Node Sampling in Endometrial Cancers
    Health Care Disparities in Gynecologic Oncology
    Clinical Trials of Oncolytic Viruses in Glioblastoma
    Circulating Tumor Cells and Cell-free Tumor DNA in Evaluation and Management of Gliomas: Current Evidence and Potential Future Clinical Use
    Optimizing Hematopoietic Cellular Transplantation in Older Adults with Hematologic Malignancies
    Moving Toward a Cure in Multiple Myeloma:Eradication of Measurable Residual Disease
    Advances in Janus-Associated Kinase Inhibitor-Based Therapies for Philadelphia Chromosome-Negative Myeloproliferative Neoplasms
    Deoxyribonucleic Acid Damage Response Defects: Clinical Implications and the Role of Poly-ADP Ribose Polymerase Inhibitors in Genitourinary Cancers and Beyond
    Clinical Trial Considerations for Bladder Preservation in Muscle-Invasive Bladder Cancer
    The Changing Demographics of Colorectal Cancer: Rising Incidence in Younger Individuals
    Total Neoadjuvant Strategies for Locally Advanced Rectal Cancer
Comments (0)